| 发明名称 |
USE OF GENETIC MARKERS FOR IDENTIFYING THE RESPONSE TO INTERFERON TREATMENT IN MULTIPLE SCLEROSIS PATIENTS |
| 摘要 |
<p>The present invention relates to the use of genetic markers to identify the response to interferon-beta (IFN-beta) treatment in Multiple Sclerosis (MS) patients as well as a method for treating MS patients and kits for genotyping.</p> |
| 申请公布号 |
EP2313522(A2) |
申请公布日期 |
2011.04.27 |
| 申请号 |
EP20090780816 |
申请日期 |
2009.07.20 |
| 申请人 |
MERCK SERONO S.A. |
发明人 |
MONNET, EMMANUEL;BOUZEKRI, NOURDINE |
| 分类号 |
C12Q1/68 |
主分类号 |
C12Q1/68 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
